Dr. Hancock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
202 N 1st St
Ste A
Booneville, MS 38829Phone+1 623-401-1386Fax+1 662-728-5185
Education & Training
University of Tennessee Health Science Center College of MedicineClass of 2014
Certifications & Licensure
MS State Medical License 2017 - 2025
AL State Medical License 2021 - 2024- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 1 citationsPhase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer.Evan Y. Yu, Michael L. Hancock, William J. Aronson, Thomas W. Flaig, Laurence Belkoff
Clinical Genitourinary Cancer. 2020-03-27 - 1 citationsA rare case of emphysematous pyelonephritis in a renal transplant patientDennis Narcisse, Manyoo Agarwal, Michael L. Hancock, Daniel Wells, Christopher W. Sands
Therapeutic Advances in Infectious Disease. 2016-11-17 - 15 citationsSelective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancerEvan Y. Yu, Robert H. Getzenberg, Christopher C. Coss, Marc M. Gittelman, Thomas E. Keane
European Urology. 2015-02-01
Press Mentions
Which Schools in Colorado Are Requiring Masks Now? Here’s a Master ListAugust 6th, 2021- Despite Delta, Sturgis Motorcycle Rally Poised to Ride AgainAugust 5th, 2021
- Denver COVID-19 Vaccination Rate of at Least One Dose Hits 70% MarkJune 10th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
